$Tempus AI (TEM.US)$ Canaccord Genuity analyst Kyle Mikson r...
$Tempus AI (TEM.US)$ Canaccord Genuity analyst Kyle Mikson reiterated a Buy rating on the stock with a $110.00 price target.
The firm is bullish on the stock, considering how AI deployment at scale in clinical practice is likely to drive robust long-term revenue growth for Tempus AI.
The research note by the firm particularly highlighted Tempus AI’s acquisition strategy, including the Ambry deal, which it believes has the potential to accelerate growth by expanding testing capabilities and enhancing AI functionalities.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment